Akums Drugs & Pharmaceuticals
AKUMS · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 6, 2024

Stock Price vs Company Growth
1d
0.6%
1w
3.2%
1m
3.2%
3m
12.3%
6m
42.9%
all
36.3%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowJun23Sep23Dec23Jun24Sep24Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

508 0.6%
434
679
Company Overview

Sales
4,145 Cr
Growth: 8.5%
Profit after Tax
375 Cr
Growth: 8.3%
Mid Cap
7,989 Cr
P/E: 19.5x
Industry P/E: 29.1x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 4,145
Growth 8.5%
EBITDA 11.2%
P/S 1.9x
Dividend 0.0%
P/E 19.5x
Book Value ₹ 1.95
PEG Ratio 2.3x
ROE 999.0%
P/B N/A
Shareholding Pattern

Institutions
Created with Highcharts 8.2.2Sep24
Promoters
Created with Highcharts 8.2.2Sep24
Others
Created with Highcharts 8.2.2Sep24
Increase    Decrease    No change
Company Profile Detailed

As a CDMO, the company produces an extensive range of dosage forms including tablets, capsules, liquid orals, vials, ampoules, blow-filled seals, topical preparations, eye drops, dry powder injections, and gummies, among others. It also engages in the marketing of trade generic and products under its own brand through distributors and alternative channels across India. Key Awards and accreditations2018: Received India Pharma Leader Award by Government of India.
Followers (1)